These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4944762)

  • 1. Evaluation of alternate-day steroid therapy for nephrotic syndrome in childhood by cross-over study.
    Yamashita F; Funatsu T; Nagayama K; Arihiro H; Anan S
    Kurume Med J; 1971; 18(3):153-60. PubMed ID: 4944762
    [No Abstract]   [Full Text] [Related]  

  • 2. Alternate-day steroid therapy in adult nephrotics.
    Gulati PD; Malik GB; Vaishnava H
    J Med; 1973; 4(5):266-75. PubMed ID: 4589645
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood.
    Barratt TM; Bercowsky A; Osofsky SG; Soothill JF
    Lancet; 1975 Jan; 1(7898):55-8. PubMed ID: 46019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the effectiveness of bolus doses of prednisolone in steroid-resistant and steroid-dependent nephrotic syndrome in children].
    Kryński J; Wyszyńska T
    Pediatr Pol; 1985 Feb; 60(2):163-8. PubMed ID: 3895148
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of alternate-day low-dose prednisolone on bone age in children with steroid-dependent nephrotic syndrome.
    Bircan Z; Soran M; Yildirim I; Dogan M; Sahin A; Bilici A; Danaci M
    Pediatr Nephrol; 1996 Jun; 10(3):397-8. PubMed ID: 8792414
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood.
    Barratt TM; Cameron JS; Chantler C; Ogg CS; Soothill JF
    Arch Dis Child; 1973 Apr; 48(4):286-90. PubMed ID: 4574639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndrome.
    Simmonds J; Grundy N; Trompeter R; Tullus K
    Arch Dis Child; 2010 Feb; 95(2):146-9. PubMed ID: 20172895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.
    Abeyagunawardena AS; Hindmarsh P; Trompeter RS
    Arch Dis Child; 2007 Jul; 92(7):585-8. PubMed ID: 17284479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to manage a child with steroid-responsive nephrotic syndrome when dose of prednisolone is reduced or when placed on high-dose alternate day steroids.
    Niaudet P
    Pediatr Nephrol; 1992 Nov; 6(6):522. PubMed ID: 1482637
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolonged prednisolone therapy in adult nephrotic syndrome: a preliminary study.
    Akinsola A; Iyun AO; Mbanefo CO; Thomas J; Akinkugbe OO
    Afr J Med Med Sci; 1988 Jun; 17(2):119-23. PubMed ID: 2458024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observations on very high-dose steroid therapy in nephrotic syndrome.
    Airede AI; Akpede GO
    Acta Paediatr; 1993 Sep; 82(9):802-3. PubMed ID: 8241683
    [No Abstract]   [Full Text] [Related]  

  • 12. Adrenal function after prednisolone treatment in childhood nephrotic syndrome.
    Sumboonnanonda A; Vongjirad A; Suntornpoch V; Petrarat S
    J Med Assoc Thai; 1994 Mar; 77(3):126-9. PubMed ID: 7798846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial.
    Raman V; Krishnamurthy S; Harichandrakumar KT
    Pediatr Nephrol; 2016 Apr; 31(4):595-604. PubMed ID: 26759000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up study of IgM associated nephrotic syndrome patients: clinical outcome and prognostic indicators.
    Kurathong P; Jesdapatarakul S
    J Med Assoc Thai; 2000 Mar; 83(3):315-24. PubMed ID: 10808687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome. The West Japan Cooperative Study of Kidney Disease in Children.
    Hiraoka M; Tsukahara H; Haruki S; Hayashi S; Takeda N; Miyagawa K; Okuhara K; Suehiro F; Ohshima Y; Mayumi M
    Kidney Int; 2000 Sep; 58(3):1247-52. PubMed ID: 10972687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood.
    Barratt TM; Soothill JF
    Lancet; 1970 Sep; 2(7671):479-82. PubMed ID: 4194935
    [No Abstract]   [Full Text] [Related]  

  • 17. Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome.
    Ekka BK; Bagga A; Srivastava RN
    Pediatr Nephrol; 1997 Oct; 11(5):597-9. PubMed ID: 9323286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new dose schedule of corticosteroids in nephrotic syndrome in infancy and childhood.
    Dikshit SK; Katiyar GP
    Indian J Med Res; 1971 Nov; 59(11):1779-87. PubMed ID: 5143168
    [No Abstract]   [Full Text] [Related]  

  • 19. Mizoribine in steroid-dependent nephrotic syndrome of childhood.
    Hamasaki T; Mori M; Kinoshita Y; Saeki T; Sakano T
    Pediatr Nephrol; 1997 Oct; 11(5):625-7. PubMed ID: 9323293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of adrenal function on steroid using renal diseases in children using the modified original ACTH tolerance test: comparing nephrotic syndrome with non-nephrotic syndrome].
    Tsuji Y; Mizuno Y; Iikura Y; Sakai T
    Nihon Jinzo Gakkai Shi; 1999 Apr; 41(2):65-9. PubMed ID: 10361421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.